Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
KSQ-001 by KSQ Therapeutics for Head And Neck Squamous Cell Carcinoma (HNSC): Likelihood of Approval
KSQ-001 is under clinical development by KSQ Therapeutics and currently in Phase II for Head And Neck Squamous Cell Carcinoma...
KSQ-001 by KSQ Therapeutics for Non-Small Cell Lung Cancer: Likelihood of Approval
KSQ-001 is under clinical development by KSQ Therapeutics and currently in Phase II for Non-Small Cell Lung Cancer. According to...
KSQ-001 by KSQ Therapeutics for Solid Tumor: Likelihood of Approval
KSQ-001 is under clinical development by KSQ Therapeutics and currently in Phase II for Solid Tumor. According to GlobalData, Phase...
KSQ-001 by KSQ Therapeutics for Metastatic Melanoma: Likelihood of Approval
KSQ-001 is under clinical development by KSQ Therapeutics and currently in Phase II for Metastatic Melanoma. According to GlobalData, Phase...